Cargando…
The Immunotherapeutic Effect of SIRPα-Silenced DCs against Cervical Cancer
Signal regulatory protein α (SIRPα), a transmembrane protein that is predominantly expressed in dendritic cells (DCs) or macrophages, interacts with CD47 that is overexpressed in almost all types of tumor cells. The interaction between SIRPα and CD47 leads to a negative signal that prevents the phen...
Autores principales: | Li, Xiaojie, Zhou, Wenying, Liang, Yanlan, Xu, Changzhi, Xie, Zhizhi, Liang, Jiayin, Hu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199593/ https://www.ncbi.nlm.nih.gov/pubmed/32411788 http://dx.doi.org/10.1155/2020/1705187 |
Ejemplares similares
-
Targeting SIRPα in cancer
por: Ho, Jenny M., et al.
Publicado: (2013) -
Signal regulatory protein alpha (SIRPα) regulates the homeostasis of CD103(+)CD11b(+) DCs in the intestinal lamina propria
por: Scott, Charlotte L, et al.
Publicado: (2014) -
Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages
por: Sakamoto, Mariko, et al.
Publicado: (2021) -
TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
por: Lin, Gloria H. Y., et al.
Publicado: (2017) -
Membrane-Mediated Cooperative Interactions of CD47 and SIRPα
por: Li, Long, et al.
Publicado: (2023)